Skip to main navigation Skip to search Skip to main content

Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab

  • Kum C. Fok
  • , Watson W. S. Ng
  • , Christopher J. A. Henderson
  • , Susan J. Connor

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Abstract

The advance of anti-tumour necrosis factor (TNF) therapy had dramatically changed the treatment algorithm of inflammatory bowel disease (IBD). This had significantly improved the quality of life for patients with Crohn's disease (CD) and ulcerative colitis (UC). However, side-effects of anti-TNF treatment were unavoidable with paradoxical inflammation (for example leucocytoclastic vasculitis and psoriasis) being well-known phenomena of anti-TNF therapy. We report a case of infliximab induced cutaneous sarcoidosis in a patient with ulcerative colitis and review the literature.
Original languageEnglish
Pages (from-to)708-712
Number of pages5
JournalJournal of Crohn's and Colitis
Volume6
Issue number6
DOIs
Publication statusPublished - 2012

Keywords

  • alanine aminotransferase
  • infliximab
  • sarcoidosis
  • side, effects
  • ulcerative colitis

Fingerprint

Dive into the research topics of 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab'. Together they form a unique fingerprint.

Cite this